VERTEX PHARMACEUTICALS INC earnings per share and revenue

VX1 earnings per share for the last quarter are 3.71 CHF whereas the estimation was 3.46 CHF which accounts for 7.41% surprise. Company revenue for the same period amounts to 2.35 B CHF despite the estimated figure of 2.28 B CHF. Estimated earnings per share for the next quarter are 3.60 CHF, and revenue is expected to reach 2.46 B CHF. Also watch annual changes over time to get a bigger picture of VX1 earnings per share and revenue dynamics.